Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.7:1
Daily Buy & Sell Volume
Transactions (256)
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
17,000
Price
$96.72
Total Value
$1.64M
Shares Held After
180,209
% of Holdings
8.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
100
Price
$110.04
Total Value
$11.00K
Shares Held After
53,609
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
1,100
Price
$109.57
Total Value
$120.53K
Shares Held After
53,709
% of Holdings
2.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,300
Price
$108.45
Total Value
$357.90K
Shares Held After
54,809
% of Holdings
5.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
730
Price
$107.17
Total Value
$78.23K
Shares Held After
58,109
% of Holdings
1.2%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$9.41
Total Value
$156.79K
Shares Held After
1,111,130
% of Holdings
1.5%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$9.41
Total Value
$47.04K
Shares Held After
1,351,053
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$9.41
Total Value
$141.12K
Shares Held After
1,599,208
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
17,000
Price
$97.46
Total Value
$1.66M
Shares Held After
197,209
% of Holdings
7.9%
Compass Therapeutics, Inc. (CMPX)
Lerner Neil — Chief Accounting Officer
Shares
20,000
Price
$0.92
Total Value
$18.40K
Shares Held After
420,000
% of Holdings
4.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
262
Price
$116.12
Total Value
$30.42K
Shares Held After
666,568
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
8,230
Price
$115.40
Total Value
$949.74K
Shares Held After
666,830
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
7,601
Price
$114.43
Total Value
$869.78K
Shares Held After
675,060
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
4,876
Price
$113.24
Total Value
$552.16K
Shares Held After
682,661
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
5,506
Price
$112.42
Total Value
$618.98K
Shares Held After
687,537
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,525
Price
$111.44
Total Value
$392.83K
Shares Held After
693,043
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
160
Price
$573.15
Total Value
$91.70K
Shares Held After
45,172
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
823
Price
$572.25
Total Value
$470.96K
Shares Held After
45,332
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
838
Price
$570.90
Total Value
$478.41K
Shares Held After
46,155
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
739
Price
$569.15
Total Value
$420.60K
Shares Held After
46,993
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
720
Price
$567.76
Total Value
$408.79K
Shares Held After
47,732
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
400
Price
$566.41
Total Value
$226.56K
Shares Held After
48,452
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,480
Price
$563.09
Total Value
$833.37K
Shares Held After
48,852
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$561.87
Total Value
$438.26K
Shares Held After
50,332
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,480
Price
$560.19
Total Value
$829.08K
Shares Held After
51,112
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
880
Price
$558.30
Total Value
$491.31K
Shares Held After
52,592
% of Holdings
1.6%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,115
Price
$375.00
Total Value
$418.12K
Shares Held After
0
% of Holdings
100.0%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
886
Price
$26.87
Total Value
$23.81K
Shares Held After
24,060
% of Holdings
3.6%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
23,170
Price
$25.78
Total Value
$597.29K
Shares Held After
24,946
% of Holdings
48.2%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
15,970
Price
$2.23
Total Value
$35.61K
Shares Held After
241,365
% of Holdings
6.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$546.23
Total Value
$196.64K
Shares Held After
326,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$545.13
Total Value
$501.52K
Shares Held After
326,723
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$544.05
Total Value
$457.00K
Shares Held After
327,643
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$543.25
Total Value
$325.95K
Shares Held After
328,483
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
580
Price
$541.76
Total Value
$314.22K
Shares Held After
329,083
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$540.78
Total Value
$259.57K
Shares Held After
329,663
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$538.65
Total Value
$21.55K
Shares Held After
330,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$537.67
Total Value
$107.53K
Shares Held After
330,183
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$536.52
Total Value
$85.84K
Shares Held After
330,383
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$531.11
Total Value
$84.98K
Shares Held After
330,543
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$526.09
Total Value
$42.09K
Shares Held After
330,703
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$524.62
Total Value
$41.97K
Shares Held After
330,783
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$523.36
Total Value
$41.87K
Shares Held After
330,863
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$517.16
Total Value
$41.37K
Shares Held After
330,943
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$514.90
Total Value
$41.19K
Shares Held After
331,023
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$511.37
Total Value
$20.45K
Shares Held After
331,103
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$495.32
Total Value
$19.81K
Shares Held After
331,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$487.79
Total Value
$39.02K
Shares Held After
331,183
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$482.36
Total Value
$77.18K
Shares Held After
331,263
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
601
Price
$480.79
Total Value
$288.96K
Shares Held After
331,423
% of Holdings
0.2%
Showing 1–50 of 256 transactions (page 1 of 6)